Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors

Grégoire Rondelet, Laurence Fleury, Céline Faux, Véronique Masson, Jean Dubois, Paola B. Arimondo, Luc Willems, Johan Wouters

Research output: Contribution to journalArticle

Abstract

Aim: DNA methyltransferases (DNMTs) are important drug targets for epigenetic therapy of cancer. Nowadays, non-nucleoside DNMT inhibitors are in development to address high toxicity of nucleoside analogs. However, these compounds still have low activity in cancer cells and mode of action of these compounds remains unclear. Materials & methods: In this work, we studied maleimide derivatives of RG108 by biochemical, structural and computational approaches to highlight their inhibition mechanism on DNMTs. Results: Findings demonstrated a correlation between cytotoxicity on mesothelioma cells of these compounds and their inhibitory potency against DNMTs. Noncovalent and covalent docking studies, supported by crystallographic (apo structure of M.HhaI) and differential scanning fluorimetry assays, provided detailed insights into their mode of action and revealed essential residues for the stabilization of such compounds inside DNMTs. </inline-graphic.

Original languageEnglish
Pages (from-to)1465-1481
Number of pages17
JournalFuture Medicinal Chemistry
Volume9
Issue number13
DOIs
Publication statusPublished - 1 Sep 2017

Fingerprint

Methyltransferases
DNA
Fluorometry
Mesothelioma
Nucleosides
Epigenomics
Neoplasms
maleimide
RG108
Pharmaceutical Preparations

Keywords

  • apoenzyme crystal structure
  • DNA methylation
  • DNA methyltransferases
  • epigenetics
  • Michael acceptor

Cite this

Rondelet, Grégoire ; Fleury, Laurence ; Faux, Céline ; Masson, Véronique ; Dubois, Jean ; Arimondo, Paola B. ; Willems, Luc ; Wouters, Johan. / Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors. In: Future Medicinal Chemistry. 2017 ; Vol. 9, No. 13. pp. 1465-1481.
@article{bcb445f2bc844953ad0add2ca114a595,
title = "Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors",
abstract = "Aim: DNA methyltransferases (DNMTs) are important drug targets for epigenetic therapy of cancer. Nowadays, non-nucleoside DNMT inhibitors are in development to address high toxicity of nucleoside analogs. However, these compounds still have low activity in cancer cells and mode of action of these compounds remains unclear. Materials & methods: In this work, we studied maleimide derivatives of RG108 by biochemical, structural and computational approaches to highlight their inhibition mechanism on DNMTs. Results: Findings demonstrated a correlation between cytotoxicity on mesothelioma cells of these compounds and their inhibitory potency against DNMTs. Noncovalent and covalent docking studies, supported by crystallographic (apo structure of M.HhaI) and differential scanning fluorimetry assays, provided detailed insights into their mode of action and revealed essential residues for the stabilization of such compounds inside DNMTs.",
keywords = "apoenzyme crystal structure, DNA methylation, DNA methyltransferases, epigenetics, Michael acceptor",
author = "Gr{\'e}goire Rondelet and Laurence Fleury and C{\'e}line Faux and V{\'e}ronique Masson and Jean Dubois and Arimondo, {Paola B.} and Luc Willems and Johan Wouters",
year = "2017",
month = "9",
day = "1",
doi = "10.4155/fmc-2017-0074",
language = "English",
volume = "9",
pages = "1465--1481",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science Ltd.",
number = "13",

}

Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors. / Rondelet, Grégoire; Fleury, Laurence; Faux, Céline; Masson, Véronique; Dubois, Jean; Arimondo, Paola B.; Willems, Luc; Wouters, Johan.

In: Future Medicinal Chemistry, Vol. 9, No. 13, 01.09.2017, p. 1465-1481.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors

AU - Rondelet, Grégoire

AU - Fleury, Laurence

AU - Faux, Céline

AU - Masson, Véronique

AU - Dubois, Jean

AU - Arimondo, Paola B.

AU - Willems, Luc

AU - Wouters, Johan

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Aim: DNA methyltransferases (DNMTs) are important drug targets for epigenetic therapy of cancer. Nowadays, non-nucleoside DNMT inhibitors are in development to address high toxicity of nucleoside analogs. However, these compounds still have low activity in cancer cells and mode of action of these compounds remains unclear. Materials & methods: In this work, we studied maleimide derivatives of RG108 by biochemical, structural and computational approaches to highlight their inhibition mechanism on DNMTs. Results: Findings demonstrated a correlation between cytotoxicity on mesothelioma cells of these compounds and their inhibitory potency against DNMTs. Noncovalent and covalent docking studies, supported by crystallographic (apo structure of M.HhaI) and differential scanning fluorimetry assays, provided detailed insights into their mode of action and revealed essential residues for the stabilization of such compounds inside DNMTs.

AB - Aim: DNA methyltransferases (DNMTs) are important drug targets for epigenetic therapy of cancer. Nowadays, non-nucleoside DNMT inhibitors are in development to address high toxicity of nucleoside analogs. However, these compounds still have low activity in cancer cells and mode of action of these compounds remains unclear. Materials & methods: In this work, we studied maleimide derivatives of RG108 by biochemical, structural and computational approaches to highlight their inhibition mechanism on DNMTs. Results: Findings demonstrated a correlation between cytotoxicity on mesothelioma cells of these compounds and their inhibitory potency against DNMTs. Noncovalent and covalent docking studies, supported by crystallographic (apo structure of M.HhaI) and differential scanning fluorimetry assays, provided detailed insights into their mode of action and revealed essential residues for the stabilization of such compounds inside DNMTs.

KW - apoenzyme crystal structure

KW - DNA methylation

KW - DNA methyltransferases

KW - epigenetics

KW - Michael acceptor

UR - http://www.scopus.com/inward/record.url?scp=85029722478&partnerID=8YFLogxK

U2 - 10.4155/fmc-2017-0074

DO - 10.4155/fmc-2017-0074

M3 - Article

AN - SCOPUS:85029722478

VL - 9

SP - 1465

EP - 1481

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 13

ER -